GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PExA AB (XSAT:PEXA B) » Definitions » EV-to-EBIT

PExA AB (XSAT:PEXA B) EV-to-EBIT : -1.41 (As of Jun. 07, 2024)


View and export this data going back to 2015. Start your Free Trial

What is PExA AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PExA AB's Enterprise Value is kr11.48 Mil. PExA AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-8.11 Mil. Therefore, PExA AB's EV-to-EBIT for today is -1.41.

The historical rank and industry rank for PExA AB's EV-to-EBIT or its related term are showing as below:

XSAT:PEXA B' s EV-to-EBIT Range Over the Past 10 Years
Min: -117.27   Med: -3.51   Max: -0.09
Current: -1.41

During the past 10 years, the highest EV-to-EBIT of PExA AB was -0.09. The lowest was -117.27. And the median was -3.51.

XSAT:PEXA B's EV-to-EBIT is ranked worse than
100% of 448 companies
in the Medical Devices & Instruments industry
Industry Median: 19.55 vs XSAT:PEXA B: -1.41

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. PExA AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr10.25 Mil. PExA AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-8.11 Mil. PExA AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -79.15%.


PExA AB EV-to-EBIT Historical Data

The historical data trend for PExA AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PExA AB EV-to-EBIT Chart

PExA AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.01 -3.68 -3.85 -1.65 -0.98

PExA AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.82 -2.23 -1.10 -0.98 -1.26

Competitive Comparison of PExA AB's EV-to-EBIT

For the Medical Devices subindustry, PExA AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PExA AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PExA AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PExA AB's EV-to-EBIT falls into.



PExA AB EV-to-EBIT Calculation

PExA AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=11.475/-8.112
=-1.41

PExA AB's current Enterprise Value is kr11.48 Mil.
PExA AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-8.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PExA AB  (XSAT:PEXA B) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

PExA AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-8.112/10.248528
=-79.15 %

PExA AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr10.25 Mil.
PExA AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-8.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PExA AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of PExA AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


PExA AB (XSAT:PEXA B) Business Description

Traded in Other Exchanges
N/A
Address
Erik Dahlbergsgatan 11A, Gothenburg, SWE, 411 26
PExA AB develops, manufactures and markets a research tool to study respiratory diseases including asthma and chronic obstructive pulmonary disease, COPD. Its product includes PExA 2.0.

PExA AB (XSAT:PEXA B) Headlines

No Headlines